Is Internal Medicine EBITDA Loss in New York Driven by AR Bottlenecks?
Yes, EBITDA loss in internal medicine practices in New York is often driven by accounts receivable (AR) bottlenecks that delay collections, increase write-offs, and weaken overall financial performance. When revenue is earned but not converted into cash on time, it directly affects profitability and limits a practice’s ability to scale and invest in growth. Internal medicine practices operate in a high-volume environment with complex payer interactions. In a state like New York, where reimbursement rules vary across multiple commercial and government payers, even small inefficiencies in the billing process can quickly compound. Over time, these inefficiencies create AR bottlenecks that slow down cash flow and reduce the ability to yield EBITDA growth. Why AR Bottlenecks Directly Impact EBITDA EBITDA is closely tied to how efficiently a practice converts billed services into collected revenue. When claims remain unpaid or delayed in AR, revenue is effectively locked. This creates ...